Clinical Efficacy and Mechanism of Yisui Granule in Treatment of Low and Medium Risk Myelodysplastic Syndrome Through Demethylation
Clinical trial NCT05687513 · UNKNOWN
Trial details
- NCT number
- NCT05687513
- Sponsor
- Dongzhimen Hospital, Beijing
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-01
- Primary completion
- 2024-02-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.